News & Analysis on Clinical Trial Services & Contract Research And Development
Accelovance has broadened its presence in China and expanded its capacity for conducting Phase I-IV clinical trials for Western pharmaceutical and biotech firms seeking to enter the Chinese market, by opening a new office in Shanghai.
Filtration system Pall Corporation reported its first quarter earnings which revealed earnings rose by 16 per cent, propelled by growth in its industrial and biopharmaceuticals segments.
Invitrogen has created three new business divisions in a move to strengthen its position in the growing biotechnology industry and drive growth through improving links between its product development cycle and customer base.
A new algorithm, which automatically selects molecule images for crystallisation in Silico studies, is set to advance laboratory studies by increasing the speed and power of methods for determining biological structures at high resolution, based on...
As low-cost contract manufacturing organisations (CMO) in Asia are becoming more attractive to drug companies, Western CMOs are having to develop new business strategies in order to compete.
After a two-year tug-of-war, the World Trade Organization (WTO) has solidified a landmark agreement to allow poor nations to import generic versions of patented drugs to treat serious diseases or epidemics.
According to a new report, the demand for worldwide drug packaging is expected to reach new heights, predicting growth of 5.3 per cent annually to $24.3 billion (€20 7 billion) in 2009, driven by aging demographic patterns increasing disease incidences.